HVSEN Biotechnology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000047H6
CNY
19.31
-0.19 (-0.97%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
420.60
396.49
404.61
353.55
227.16
204.50
325.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
420.60
396.49
404.61
353.55
227.16
204.50
325.39
Raw Material Cost
303.05
310.19
348.54
315.33
204.35
170.94
275.63
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.46
9.16
8.47
12.68
11.11
10.41
11.60
Selling and Distribution Expenses
25.38
28.44
20.86
30.64
20.58
19.73
52.03
Other Expenses
1.26
0.31
0.62
-0.24
-0.13
0.20
-0.01
Total Expenditure (Excl Depreciation)
343.52
350.94
384.07
356.29
234.71
203.05
339.20
Operating Profit (PBDIT) excl Other Income
77.1
45.5
20.5
-2.7
-7.5
1.5
-13.799999999999999
Other Income
10.46
6.33
6.11
5.84
7.48
7.54
15.01
Operating Profit (PBDIT)
116.26
80.82
55.83
33.56
26.56
34.64
34.63
Interest
2.46
9.16
8.47
12.68
11.11
10.41
11.60
Exceptional Items
-1.22
8.71
13.81
11.55
-30.91
-18.09
7.98
Gross Profit (PBDT)
117.54
86.30
56.06
38.22
22.81
33.56
49.76
Depreciation
29.69
29.69
28.95
28.95
27.69
27.69
33.21
Profit Before Tax
82.89
50.68
32.23
3.48
-43.14
-21.55
-2.20
Tax
10.13
5.90
4.39
-0.78
-7.67
-5.14
-4.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
72.68
44.50
27.50
4.22
-35.47
-16.41
1.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
72.68
44.50
27.50
4.22
-35.47
-16.41
1.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.08
0.28
0.34
0.04
-0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
72.77
44.78
27.84
4.26
-35.47
-16.41
1.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,058.59
1,578.25
1,457.58
1,422.69
1,429.74
1,509.78
1,509.28
Earnings per share (EPS)
0.39
0.25
0.17
0.03
-0.22
-0.1
0.01
Diluted Earnings per share
0.39
0.25
0.17
0.03
-0.22
-0.1
0.01
Operating Profit Margin (Excl OI)
18.1%
11.3%
5.13%
-0.35%
-3.79%
-0.29%
-4.18%
Gross Profit Margin
26.77%
20.27%
15.12%
9.17%
-6.8%
3.0%
9.53%
PAT Margin
17.28%
11.22%
6.8%
1.19%
-15.62%
-8.02%
0.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 6.08% vs -2.00% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 62.50% vs 61.15% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 42.01% vs 49.90% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -72.83% vs 8.24% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of HVSEN Biotechnology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
420.60
0
420.60
Other Operating Income
0.00
0.00
0.00
Total Operating income
420.60
0
420.60
Raw Material Cost
303.05
0
303.05
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.46
0
2.46
Selling and Distribution Expenses
25.38
0
25.38
Other Expenses
1.26
0.00
1.26
Total Expenditure (Excl Depreciation)
343.52
0
343.52
Operating Profit (PBDIT) excl Other Income
77.07
0.00
77.07
Other Income
10.46
0
10.46
Operating Profit (PBDIT)
116.26
0
116.26
Interest
2.46
0
2.46
Exceptional Items
-1.22
0
-1.22
Gross Profit (PBDT)
117.54
0
117.54
Depreciation
29.69
0
29.69
Profit Before Tax
82.89
0
82.89
Tax
10.13
0
10.13
Provisions and contingencies
0
0
0.00
Profit After Tax
72.68
0
72.68
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
72.68
0
72.68
Share in Profit of Associates
0
0
0.00
Minority Interest
0.08
0
0.08
Other related items
0.00
0.00
0.00
Consolidated Net Profit
72.77
0
72.77
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,058.59
0
2,058.59
Earnings per share (EPS)
0.39
0
0.39
Diluted Earnings per share
0.39
0
0.39
Operating Profit Margin (Excl OI)
18.10%
0%
0.00
18.10%
Gross Profit Margin
26.77%
0%
0.00
26.77%
PAT Margin
17.28%
0%
0.00
17.28%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 42.06 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 6.08% vs -2.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 85.12% vs 5.04% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 7.28 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 62.50% vs 61.15% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 305.07% vs -3,650.00% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.58 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 42.01% vs 49.90% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 453.93% vs -35.03% in Jun 2024

Quarterly - Interest
Interest 0.25 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -72.83% vs 8.24% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -77.48% vs 122.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.10%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024